CHD

Business Context and Reporting Period

Company: Church & Dwight Co., Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 26, 2003
Business Overview: The Company manufactures and markets consumer and specialty products, including deodorizing and cleaning products, laundry products, personal care products, and specialty chemicals. A significant portion of its operations involves unconsolidated affiliates, most notably Armkel LLC (a 50% joint venture).

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Net sales increased 0.7% in the quarter and decreased 1.1% year-to-date compared to 2002. Growth in liquid laundry detergent and international sales was offset by declines in powder detergent and oral care products.
• Profitability: Net income increased 11% in the quarter and 27% year-to-date. Diluted EPS rose from $0.42 to $0.46 (quarter) and $1.23 to $1.55 (nine months).
• Margin Expansion: Gross margin improved to 30.4% year-to-date from 29.6% in the prior year, driven by integration benefits and manufacturing efficiencies, despite higher raw material costs (palm oil derivatives) in the Specialty segment.
• Equity Earnings: Equity in earnings of affiliates increased significantly year-to-date ($8.1 million) due to a $12.7 million litigation settlement gain at Armkel LLC, partially offset by an impairment charge.
• Debt Structure: The Company refinanced $100 million of Term Loan debt via the issuance of 5.25% convertible senior debentures in August 2003. Term Loan A was paid off in full during the second quarter.

Guidance, Outlook, and Risks

• Recent Acquisition: On October 20, 2003 (post-period), the Company acquired four oral care brands from Unilever (Mentadent, Pepsodent, Aim, Close-Up) for approximately $104 million in cash plus contingent payments. This transaction triples the Company's unit sales in the U.S. oral care sector.
• Cost Outlook: Management expects over $10 million in energy and commodity cost increases (resin, surfactants, palm oil) for the year but anticipates achieving gross margin improvement through efficiency gains.
• Accounting Risks: The Company is evaluating the impact of FASB FIN No. 46 regarding the consolidation of its Armkel LLC joint venture. If consolidated, total assets would rise to approximately $1.7 billion and liabilities to $1.2 billion, though net income would remain unchanged.
• Contingencies: Potential liability exists regarding litigation involving former Carter-Wallace shareholders, with potential exposure up to $2.1 million directly to the Company and up to $12 million to Armkel.
• Product Recall: A safety recall of a single item in the Sno Bol toilet bowl cleaner line negatively impacted cleaner sales in the quarter.

Investor Verification Checklist

• Armkel Consolidation: Verify the final determination on FIN No. 46 regarding Armkel LLC and its impact on future balance sheet leverage ratios.
• Unilever Integration: Monitor the integration progress and financial contribution of the newly acquired oral care brands (Mentadent, Pepsodent, Aim, Close-Up) in Q4 2003 and 2004.
• Convertible Debentures: Track the stock price relative to the $46.50 conversion price to assess potential dilution from the $100 million convertible senior debentures issued in August 2003.
• Raw Material Costs: Confirm the Company's ability to offset the projected $10 million+ increase in commodity costs through pricing or efficiency measures.
• Litigation Resolution: Monitor the status of the Carter-Wallace shareholder litigation to ensure no material adverse liability materializes.